Laboratorios Bilper SL

Based in Spain, Laboratorios Bilper SL specializes in the development and manufacturing of bio and vegan-friendly cosmetic and hygiene products for companion animals, serving various sectors including clinical and food industries. Laboratorios Bilper SL focuses on creating high-quality products for pet hygiene and health. Founded in 1958, the company is headquartered in Spain and has engaged in one notable transaction, with Stellum Capital acquiring a majority stake on November 3, 2025. There are no known pivots or subsidiaries associated with the company.

Laboratorios Bilper specializes in the development and manufacturing of high-quality bio and vegan-friendly cosmetic and hygiene products for companion animals. With over 40 years of experience, the company offers a comprehensive range of products designed for clinical and hospital use, as well as applications in the food industry and collective settings. Their core offerings include Menforsan, a line of health and hygiene products tailored for pets, and Bacterisan, featuring environmentally friendly disinfectants, detergents, and insecticides. The products utilize exclusive formulations ensuring stability, effectiveness, and extended shelf life, all rigorously tested under pharmaceutical, veterinary, and chemical controls, primarily marketed in Europe.

Laboratorios Bilper generates revenue through a diverse transaction structure that includes direct sales to consumers and partnerships with retailers and wholesalers. The company’s flagship products, including its Menforsan and Bacterisan lines, are offered through these channels, ensuring accessibility to a broad customer base. The pricing strategy employs competitive pricing for individual products, allowing pet owners and businesses in the food and healthcare sectors to purchase based on specific use cases. This approach supports both B2B transactions with veterinary clinics and businesses, as well as direct-to-consumer sales through various distribution platforms.

The firm’s longstanding reputation, established since 1958, contributes to customer loyalty and market presence in the pet care industry. In November 2025, Stellum Capital acquired a majority stake in Laboratorios Bilper SL, providing the company with an opportunity to expand its product offerings and market reach. Future growth strategies include the design and launch of new product lines aimed to enhance the company's portfolio, with specific timelines yet to be announced. Additionally, Laboratorios Bilper is targeting expansion into new geographic regions to reach a broader customer base, aligning with the strategic goals facilitated by the recent acquisition.